Algentech

Algentech Granted US Patent For A Key Genome Editing Technology

Gene editing

Home » Emerging technologies » Gene editing » Page 2

CRISPR

Fast-forward 10 years from now. What does the CRISPR genome editing field look like to you?

Beam Therapeutics Announces Collaboration and Exclusive License Agreement with Prime Medicine for Prime Editing Technology

How Inscripta’s Onyx platform is making creativity the biologist’s only limiting factor

RNA polymerase II

Top synthetic biology news from academic labs in 2019

John Lesnick

How Automation and Machine Learning Help Explore the Dark Corners of the Genome

Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineering

CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology

Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases

Inscripta

Watch Kevin Ness’ keynote during SynBioBeta 2019: Digital Genome Engineering – Unlocking the Unlimited Potential of Biology

Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell Medicines